Editorial [ Review Articles ]

Conventional drug development, which likely to be remain a dominant strategy in the near future, is based on the discovery of potent molecular entities. Scientific literature is full of the reports of discovery or development of interesting molecular exciting against different therapeutic targets. However, only a handful of these exciting discoveries are seriously followed mainly due to lack of access to most readily available and updated literature reports. The quarterly journal Current Bioactive Compounds is an attempt to fill this gap. We are glad that this journal has already received attention of the fraternity scientists working in the field of drug development and discovery. This issue of Current Bioactive Compounds contains brief descriptions and chemical structures of lead discoveries, taken from the most authentic literature sources, and divided into thirteen therapeutic categories. This will hopefully enable readers to quickly spot the potential leads for further exploration. Keeping in view of the importance of in-depth analysis of various classes of bioactive compounds against various diseases, we have decided to include selected review articles in CBC starting from this issue. The articles are contributed by leading researchers in the field and focuses on various classes of bioactive chemical compounds along with their mechanisms of action and structure-activity relationships. I hope this innovation in the format and scope of the Current Bioactive Compounds will be welcomed by the readers and will further enhance this impact of the publication. At the end we acknowledge the editorial and secretarial staff of the Bentham Science Publishers, for their help in bringing this issue timely and neatly. Notable among them are the team leader Mr. Mahmood Alam, and staff members, Dr. Ghulam Murtaza Maharvi and Miss Samreen Laeeq.